Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cue Biopharma, Inc. - Common Stock
(NQ:
CUE
)
28.77
-1.66 (-5.44%)
Streaming Delayed Price
Updated: 12:38 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cue Biopharma, Inc. - Common Stock
< Previous
1
2
3
Next >
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 31, 2025
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Inc. (NASDAQ: CUE) Leading the Way in Wednesday Trading Based on Percentage Gain
March 13, 2024
Via
Investor Brand Network
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 14, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Strategic Organizational Transition
November 14, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
November 12, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
November 08, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
October 04, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Proposed Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Proposed Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
September 09, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
September 03, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 19, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Host Business Update Call and Webcast
August 13, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements
July 25, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
June 04, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
June 03, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
May 08, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
May 07, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
April 08, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Host Business Update Call and Webcast
April 02, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
February 29, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
November 22, 2023
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
November 07, 2023
From
Cue Biopharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
